-
An elevated resting heart rate is a risk factor for heart disease.
-
Fortunately, at a time when there is an emphasis on evidence-based reasons for medical decisions, more reviews are appearing in the literature looking at various common interventions and the evidence available to support these practices.
-
In this issue: Aspirin dose and cardioprotection; uncovering modafinil's abuse potential; proton-pump inhibitors and clopidogrel; FDA actions.
-
The Women's Health Initiative reported the effects on overall mortality in their randomized trial of calcium and vitamin D supplementation.
-
In a retrospective analysis of 3681 women who underwent endometrial ablation from 1999 to 2004, data analyzed in 2007 from Northern California Kaiser Permanente showed hysterectomy was performed in 21% (774 patients) while uterine-sparing surgery was performed in another 3.9% (n = 143).
-
The ECG shown above was obtained from a 60-year-old woman who presented with an acute stroke. Is her ECG consistent with this diagnosis, and/or suggestive of something more?
-
Ranolazine has gained expanded approval from the FDA for the treatment of chronic angina.
-
Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
-
-
In light of an increasing internationally mobile community, the primary care physician may see patients who have recently traveled overseas. This article highlights the manifestations of diseases that, although we may not see them often, can fool us with confusing symptoms.